Thank you, Dr. Powlowski.
Mr. Chair, I'd like to take that question back, if that's okay, given the time and given my relative lack of expertise in infectious diseases and therapeutics.
We have a drugs and biologics working group that is looking at that. I appreciate the question and can get back to you through the clerk, if that's acceptable.